Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Cost of treating otitis media in Australia

Taylor, P., Faeth, I., Marks, M., Delmar, C., Skull, Susan, Pezzullo, M., Havyatt, S. and Coates, H. (2009). Cost of treating otitis media in Australia. Expert Review of Pharmacoeconomics and Outcomes Research: informing decision-making in the delivery of cost-effective healthcare,9(2):133-141.

Document type: Journal Article
Citation counts:
Google Scholar Search Google Scholar

IRMA ID 10619xPUB17
Title Cost of treating otitis media in Australia
Author Taylor, P.
Faeth, I.
Marks, M.
Delmar, C.
Skull, Susan
Pezzullo, M.
Havyatt, S.
Coates, H.
Journal Name Expert Review of Pharmacoeconomics and Outcomes Research: informing decision-making in the delivery of cost-effective healthcare
Publication Date 2009
Volume Number 9
Issue Number 2
ISSN 1473-7167   (check CDU catalogue open catalogue search in new window)
Start Page 133
End Page 141
Total Pages 9
Place of Publication UK
Publisher Expert Reviews
HERDC Category C1 - Journal Article (DEST)
Abstract Objective: Otitis media (OM) is an inflammation of the middle ear. It is very common and associated with serious complications, including hearing loss. This study aimed to estimate the treatment costs of OM in Australia and the associated burden of disease (in disability-adjusted life-years).

Methods: Little Australia-wide epidemiological information is available, so international studies in the main were used to estimate the incidence and prevalence by age and gender. These were triangulated against the available Australian data. Australian health data sets and data collected from the emergency department of a tertiary pediatric hospital were used to estimate the costs of primary care, pharmaceuticals, pathology and imaging, emergency department presentations, specialists, and admitted hospital care.

Results: Excluding the costs of the complications and comorbidities associated with OM, treatment costs for the disease in 2008 were between AUS$100 and 400 million. Visits to general practitioners and medicines constituted a high proportion of these costs. Antibiotic prescribing rates remain high despite clear evidence for a limited benefit from antibiotics for most OM cases and concerns regarding bacterial resistance.

Conclusion: Treatment costs of OM in Australia are high and can only be estimated within a broad range. Further research on the links between antibiotics for OM and antibiotic resistance, and on the cost-effectiveness of prevention or amelioration of OM would be useful.
Keywords antibiotic prescribing
Australia
disease costing
incidence
otitis media
prevalence
treatment cost
DOI http://dx.doi.org/10.1586/erp.09.6   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)
 
Versions
Version Filter Type
Access Statistics: 95 Abstract Views  -  Detailed Statistics
Created: Wed, 03 Mar 2010, 23:57:14 CST